Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

Author： Friedman Joseph  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.174, Iss.1, 2004-06, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role of the cholinesterase inhibitors in the treatment of schizophrenia

By Pae Chi-Un  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 293-298

Informa Healthcare

Access to resources Recommend Favorite

[General Articles] Muscarinic and Nicotinic Cholinergic Agonists: Structural Analogies and Discrepancies

By  

Current Medicinal Chemistry, Vol. 10, Iss. 23, 2003-12 ,pp. : 2611-2620

Bentham Science Publishers

Access to resources Recommend Favorite

Treating Schizophrenia: Novel Targets for the Cholinergic System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2093-2116

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic Adverse Effects of Cholinesterase Inhibitors in Alzheimer's Disease: Epidemiology and Management

By Gauthier S.  

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 853-862

Adis International

Access to resources Recommend Favorite